Literature DB >> 18343921

Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both?

Karin E de Visser1.   

Abstract

Cancer cells cannot develop into invasive cancers without interactions with cells and soluble mediators present in the tumor microenvironment. Accumulating evidence indicates that the immune system is a critical determinant of malignant outgrowth; however, the tumor-modulating effects of spontaneous immune responses towards nascent malignancies are rather paradoxical. Both cancer-protective and cancer-promoting features of the immune system have been described. This review will discuss the role of the dynamic inflammatory tumor microenvironment during cancer development and progression, and will focus on the intriguing question: "Do malignancies develop in spite of-or because of-spontaneous immune responses?" Special emphasis will be put on recent progress in our understanding of the immune system's double-edged sword function during de novo carcinogenesis.

Entities:  

Mesh:

Year:  2008        PMID: 18343921     DOI: 10.1007/s00262-008-0501-x

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  13 in total

Review 1.  The emerging understanding of myeloid cells as partners and targets in tumor rejection.

Authors:  Miranda L Broz; Matthew F Krummel
Journal:  Cancer Immunol Res       Date:  2015-04       Impact factor: 11.151

2.  Autoantibodies to mesothelin in infertility.

Authors:  Judith L Luborsky; Yi Yu; Seby L Edassery; Jade Jaffar; Yuan Yee Yip; Pu Liu; Karl Eric Hellstrom; Ingegerd Hellstrom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-08-16       Impact factor: 4.254

3.  Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.

Authors:  Toshifumi Fujiwara; Jun-ichi Fukushi; Shunsaku Yamamoto; Yoshihiro Matsumoto; Nokitaka Setsu; Yoshinao Oda; Hisakata Yamada; Seiji Okada; Kosuke Watari; Mayumi Ono; Michihiko Kuwano; Satoshi Kamura; Keiichiro Iida; Yuko Okada; Mihoko Koga; Yukihide Iwamoto
Journal:  Am J Pathol       Date:  2011-07-21       Impact factor: 4.307

4.  When neighbourhood matters: tumour microenvironment.

Authors:  M Pérez-Moreno
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

5.  Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer.

Authors:  Tomoharu Miyashita; Kenji Miki; Takashi Kamigaki; Isamu Makino; Hisatoshi Nakagawara; Hidehiro Tajima; Hiroyuki Takamura; Hirohisa Kitagawa; Sachio Fushida; Ali K Ahmed; Mark D Duncan; John W Harmon; Tetsuo Ohta
Journal:  Clin Exp Med       Date:  2015-10-08       Impact factor: 3.984

6.  Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study.

Authors:  Angeline S Andrew; Jiang Gui; Ting Hu; Asaf Wyszynski; Carmen J Marsit; Karl T Kelsey; Alan R Schned; Sam A Tanyos; Eben M Pendleton; Rebecca M Ekstrom; Zhongze Li; Michael S Zens; Mark Borsuk; Jason H Moore; Margaret R Karagas
Journal:  BJU Int       Date:  2014-03-26       Impact factor: 5.588

7.  Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors.

Authors:  Michael J Bradaric; Animesh Barua; Krishna Penumatsa; Yu Yi; Seby L Edassery; Sameer Sharma; Jacques S Abramowicz; Janice M Bahr; Judith L Luborsky
Journal:  J Ovarian Res       Date:  2011-02-28       Impact factor: 4.234

8.  Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure.

Authors:  Maciej Kmieciak; Kyle K Payne; Michael O Idowu; Margaret M Grimes; Laura Graham; Maria-Libera Ascierto; Ena Wang; Xiang-Yang Wang; Harry D Bear; Masoud H Manjili
Journal:  J Transl Med       Date:  2011-03-31       Impact factor: 5.531

9.  HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer.

Authors:  Angeline S Andrew; Ting Hu; Jian Gu; Jiang Gui; Yuanqing Ye; Carmen J Marsit; Karl T Kelsey; Alan R Schned; Sam A Tanyos; Eben M Pendleton; Rebecca A Mason; Elaine V Morlock; Michael S Zens; Zhongze Li; Jason H Moore; Xifeng Wu; Margaret R Karagas
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

10.  A mixture of amino acids and other small molecules present in the serum suppresses the growth of murine and human tumors in vivo.

Authors:  Gyula Kulcsár; Dezső Gaál; Péter I Kulcsár; Ákos Schulcz; Tamás Czömpöly
Journal:  Int J Cancer       Date:  2012-08-24       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.